Long term outcome of percutaneous mitral balloon valvotomy in patients aged 70 and over

N Sutaria1, A T Elder, T R Shaw

  • 1Department of Cardiology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK.

Insights

Percutaneous mitral balloon valvotomy offers significant hemodynamic improvement and symptomatic relief in elderly patients over 70. This safe procedure provides a valuable palliative option for those unsuitable for surgery.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Severe mitral stenosis in elderly patients presents a significant clinical challenge.
  • Surgical intervention for mitral stenosis in patients over 70 is often associated with high risk due to comorbidities.
  • Percutaneous mitral balloon valvotomy (PMBV) has emerged as a less invasive alternative.

Purpose of the Study:

  • To evaluate the immediate hemodynamic effects of PMBV.
  • To assess the long-term symptomatic benefits of PMBV in patients aged 70 years and older.
  • To determine the safety and efficacy of PMBV as a palliative treatment in this population.

Main Methods:

  • A prospective study was conducted at a tertiary referral center.
  • Eighty patients aged 70 and above underwent PMBV.
  • Hemodynamic parameters were measured pre- and post-procedure, with follow-up ranging from 1 to 10 years.

Main Results:

  • PMBV resulted in an 89% increase in mitral valve area (from 0.84 to 1.59 cm²).
  • Complication rates were low, with only two patients experiencing long-term major sequelae.
  • At 5 years, 25% of surgically unsuitable patients and 36% of suitable patients remained free from valve replacement and showed symptom improvement.

Conclusions:

  • PMBV is a safe and effective palliative procedure for elderly patients with mitral stenosis, particularly those unsuitable for surgery.
  • The procedure offers significant hemodynamic improvement and long-term symptomatic benefit.
  • While echo score is used to predict outcomes, it is an imperfect predictor of hemodynamic improvement.
Abstract

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...